Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Complement C1q-C3 associated synaptic changes in multiple sclerosis hippocampus.
Applications of coherent Raman scattering microscopies to clinical and biological studies.
Fibroblast growth factor signalling in multiple sclerosis: inhibition of myelination and induction of pro-inflammatory environment by FGF9.
An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration.
Pathologic laughing as a presenting feature in a patient with neuromyelitis optica.
T lymphocyte proliferation is suppressed by the opioid growth factor ([Met(5)]-enkephalin)-opioid growth factor receptor axis: implication for the treatment of autoimmune diseases.
Regulatory B cells, helminths, and multiple sclerosis.
Linear pontine trigeminal root and trigeminal nerve lesions in multiple sclerosis.
New and emerging immune-targeted drugs for the treatment of multiple sclerosis.
Promoting return of function in multiple sclerosis: An integrated approach.
Secondary hemophagocytic lymphohistiocytosis possibly induced by interferon beta-1a therapy.
Treatment of cognitive impairment in multiple sclerosis: position paper.
Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status.
Clinical and Radiological Characteristics in Multiple Sclerosis Patients with Large Cavitary Lesions.
Prophylactic and abundant intake of α-lipoic acid causes hepatic steatosis and should be reconsidered in usage as an anti-aging drug.
The Standards of Reporting of Neurological Disorders (STROND) checklist: Application to multiple sclerosis.
Comparison of myelin water fraction values in periventricular white matter lesions between multiple sclerosis and neuromyelitis optica spectrum disorder.
Disconnection of the hippocampus and amygdala associated with lesion load in relapsing-remitting multiple sclerosis: a structural and functional connectivity study.
Myeloid derived suppressor cells in inflammatory conditions of the central nervous system.
Oligodendrocyte Development and Myelination in Neurodevelopment: Molecular Mechanisms in Health and Disease.
The impact of persistence with therapy on inpatient admissions and emergency room visits in the US among patients with multiple sclerosis.
Delayed P100-Like Latencies in Multiple Sclerosis: A Preliminary Investigation Using Visual Evoked Spread Spectrum Analysis.
IFNAR signaling directly modulates T lymphocyte activity, resulting in milder experimental autoimmune encephalomyelitis development.
Choline-Containing Phospholipids: Structure-Activity Relationships Versus Therapeutic Applications.
Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity.
Pages
« first
‹ previous
…
439
440
441
442
443
444
445
446
447
…
next ›
last »